Search Results 731-740 of 7049 for 不留痕搜索咨询邮箱：lgooxc@hotmail.com
The purpose of the study is to evaluate the safety of Rifaximin or placebo in subjects with severe hepatic impairment and Hepatic Encephalopathy. Participation ...
Fostering an outstanding academic faculty dedicated to the development and delivery of educational programs to train biomedical researchers; Working with Mayo ...
Faculty including scientists, engineers and physicians work together in the Department of Physiology and Biomedical Engineering at Mayo Clinic.
About this study. This randomized phase III trial studies how well combination chemotherapy (vincristine sulfate, dactinomycin, cyclophosphamide alternated ...
If an MTD cannot be identified, a recommended phase 2 dose (RP2D) will be determined. In addition, two tumor specific extension cohorts may be conducted to ...
About this study. RESPOND-HF is a prospective, multi-center, non-significant risk pilot study with cross-over design. The purpose of the study is to ...
About this study. The purpose of this study is to determine if ultrasound surface wave elastography (USWE) produces different recording patterns in healthy ...
Education · 2005. Fellow - CytopathologyUniversity of Chicago Hospitals · 2004. Resident - Anatomic and Clinical PathologyUniversity of Chicago Medical Center.
About this study. The purpose of this study is that the Oxalosis and Hyperoxaluria Foundation (OHF) Registry in collaboration with the Mayo Clinic will ...
Pazopanib hydrochloride may also stop the growth of kidney cancer by blocking blood flow to the tumor. Participation eligibility. Participant eligibility ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.